Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

NCT03798626

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: University of California LA Los Angeles, California, United States

WA Uni School Of Med St Louis, Missouri, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

Novartis Investigative Site Melbourne, Victoria, Australia

View all 34 locations

View Trial Details

Completed

Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma

NCT02555748

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: CHU DE BORDEAUX - Hôpital Saint-André Bordeaux, France

Institut Bergonie Bordeaux, France

CHU DE LIMOGES - Hôpital Dupuytren Limoges, France

Centre Leon Berard Lyon, France

View Trial Details

Completed

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

NCT02690558

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: North Carolina Cancer Hospital (UNC) Chapel Hill, North Carolina, United States

Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Symptomatic and Incidental RCC Detection

NCT07004426

Conditions: Adenocarcinoma, Benign Renal Neoplasm, Carcinoma, +16 more
Locations: University Hospital Královské Vinohrady Prague, Czechia

View Trial Details

Completed

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

NCT04960059

Conditions: Adenocarcinoma, Bronchial Neoplasms, Cancer, +34 more
Locations: The Christie NHS Foundation Trust Manchester, United Kingdom

View Trial Details

Completed

Recovery Support for Bladder Cancer Patients and Caregivers

NCT04055311

Conditions: Behavior, Bladder Cancer, Female Urogenital Diseases, +17 more
Locations: Northwell Health Manhasset, New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Evaluation of VISIOCYT Bladder Cytology in Real Life

NCT06072027

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Institut Paoli-Calmettes Marseille, France

View Trial Details

Completed

Study of DF6215 in Patients With Advanced Solid Tumors

NCT06108479

Conditions: Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +42 more
Locations: The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States

University of California Irvine Medical Center Orange, California, United States

University of California San Diego Moores Cancer Center San Diego, California, United States

Sarcoma Oncology Center Santa Monica, California, United States

View all 21 locations

View Trial Details

Completed

COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT

NCT07481123

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Ankara Etlik City Hospital Ankara, Turkey (Türkiye)

View Trial Details

Completed

A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

NCT06894771

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +45 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301) Hackensack, New Jersey, United States

NEXT Oncology ( Site 0300) San Antonio, Texas, United States

Princess Margaret Cancer Center ( Site 0101) Toronto, Ontario, Canada

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0102) Québec, Quebec, Canada

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions